[Level of alpha-granule membrane protein (CD62P) in coronary heart disease]

Jun-Ming Cai1, Tao Li, Yun-Qi Zhang

  • 1Department of Cardiology, Shenzhen Pingshan People's Hospital, Shenzhen 518000, China.

Zhonghua Yi Xue Za Zhi
|March 21, 2008
PubMed

Insights

Platelet activation marker CD62P is elevated in patients with unstable angina pectoris (UAP) and correlates with coronary artery stenosis severity. This finding highlights CD62P

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Context:

  • Coronary heart disease (CHD) involves complex pathophysiological processes including platelet activation.
  • Platelet activation is a critical factor in the development and progression of atherosclerotic disease.
  • Assessing platelet activation markers can provide insights into disease severity and patient prognosis.

Purpose:

  • To investigate the role of platelet alpha-granule membrane protein (CD62P) in patients with coronary heart disease (CHD).
  • To determine the relationship between CD62P levels and the severity of coronary artery stenosis.
  • To compare CD62P levels across different clinical presentations of CHD (stable angina, unstable angina, acute myocardial infarction) and healthy controls.

Summary:

  • The study analyzed CD62P levels in 70 CHD patients (stable angina, unstable angina, acute myocardial infarction) and 20 controls using flow cytometry.
  • CD62P positive rates were significantly higher in unstable angina pectoris (UAP) patients compared to stable angina pectoris (SAP) and no-CHD groups.
  • Elevated CD62P levels were also observed in patients with multi-vessel coronary artery disease, indicating a correlation with stenosis severity.

Impact:

  • The findings suggest that CD62P is a valuable biomarker for platelet activation in CHD, particularly in UAP.
  • Elevated CD62P levels are associated with the pathophysiological processes underlying UAP and the extent of coronary artery stenosis.
  • This research may contribute to improved diagnostic and prognostic strategies for patients with coronary heart disease.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...